Sign In
Buy PGNY
$26.28
+0.200 (+0.767%)
At Close: Jun 22, 2026
Progyny: A Winner For Years To Come
03:28pm, Thursday, 22'nd Dec 2022
Compared to many newly listed public companies in recent years, Progyny is thriving as client count and revenues have grown tremendously. Progyny is the market leader in the fertility benefits arena,
ELV vs. PGNY: Which Stock Is the Better Value Option?
12:48pm, Friday, 16'th Dec 2022
ELV vs. PGNY: Which Stock Is the Better Value Option?
Looking for Earnings Beat? Buy These 5 Stocks With Potential
06:47am, Friday, 16'th Dec 2022
These top-ranked stocks -- Chewy (CHWY), Progyny (PGNY), KnowBe4 (KNBE), Chegg (CHGG) and Fortinet (FTNT) -- are likely to beat on their bottom line in the next releases.
Progyny CEO says economic turbulence isn't hurting business
07:29pm, Thursday, 08'th Dec 2022
Cramer spoke with Progyny CEO Peter Anevski on Thursday.
ELV vs. PGNY: Which Stock Should Value Investors Buy Now?
12:47pm, Monday, 28'th Nov 2022
ELV vs. PGNY: Which Stock Is the Better Value Option?
Progyny stock grows after fertility drug shipments resume, upping 4Q guidance
11:28am, Monday, 28'th Nov 2022
Progyny Inc (NASDAQ:PGNY) announced that shipments of its fertility medication Menopur have resumed following an industry wide shortage, prompting the company to boost its fourth quarter and full year
Fertility manager Progyny stock gains as resumption of Menopur deliveries leads to raised guidance
08:16am, Monday, 28'th Nov 2022
Shares of Progyny Inc. PGNY, +0.17% gained 0.4% in premarket trading Monday, after the fertility benefits management company raised is fourth-quarter financial outlook, given the surprising resumption
ELV or PGNY: Which Is the Better Value Stock Right Now?
12:47pm, Friday, 11'th Nov 2022
ELV vs. PGNY: Which Stock Is the Better Value Option?
Progyny, Inc. to Present at Credit Suisse 31st Annual Healthcare Conference
12:00pm, Friday, 04'th Nov 2022
NEW YORK, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that P
Progyny, Inc. (PGNY) CEO Peter Anevski on Q3 2022 Results - Earnings Call Transcript
01:00am, Friday, 04'th Nov 2022
Progyny, Inc. (NASDAQ:PGNY ) Q3 2022 Earnings Conference Call November 3, 2022 4:45 PM ET Company Participants James Hart - VP, IR Peter Anevski - CEO Mark Livingston - CFO Conference Call Participant
Progyny (PGNY) Q3 Earnings and Revenues Top Estimates
06:51pm, Thursday, 03'rd Nov 2022
Progyny (PGNY) delivered earnings and revenue surprises of 160% and 5.64%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
ELV or PGNY: Which Is the Better Value Stock Right Now?
12:48pm, Friday, 21'st Oct 2022
ELV vs. PGNY: Which Stock Is the Better Value Option?
Progyny (PGNY) Upgraded to Buy: Here's What You Should Know
01:33pm, Thursday, 29'th Sep 2022
Progyny (PGNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
AMN or PGNY: Which Is the Better Value Stock Right Now?
12:47pm, Wednesday, 28'th Sep 2022
AMN vs. PGNY: Which Stock Is the Better Value Option?
MODV vs. PGNY: Which Stock Is the Better Value Option?
12:48pm, Friday, 09'th Sep 2022
MODV vs. PGNY: Which Stock Is the Better Value Option?
